Syndax Pharmaceuticals, Inc. (SNDX)
19.41
-0.82
(-4.05%)
USD |
NASDAQ |
May 18, 16:00
19.41
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Liabilities (Quarterly) : 431.05M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 295.31M |
| Vera Therapeutics, Inc. | 122.04M |
| Biogen, Inc. | 10.83B |
| Amgen, Inc. | 83.31B |
| Ardelyx, Inc. | 355.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 472.67M |
| Shareholders Equity (Quarterly) | 41.62M |
| Debt to Equity Ratio | 8.298 |
| Current Ratio | 5.468 |
| Net Debt Paydown Yield | 0.00% |